Lepzacitinib

Names

[ CAS No. ]:
2321488-47-3

[ Name ]:
Lepzacitinib

Biological Activity

[Description]:

Lepzacitinib is a Janus kinase inhibitor targeting to JAK 1/3. Lepzacitinib exhibits anti-inflammatory effect and inhibits atopic dermatitis and other skin diseases[1].

[Related Catalog]:

Signaling Pathways >> JAK/STAT Signaling >> JAK
Signaling Pathways >> Epigenetics >> JAK
Signaling Pathways >> Stem Cell/Wnt >> JAK
Research Areas >> Inflammation/Immunology

[Target]

JAK 1/3[1]


[References]

[1]. Anderson, et al. Preparation of substituted pyrrolopyridine compounds as JAK inhibitors. World Intellectual Property Organization, WO2019090158 A1 2019-05-09.

Chemical & Physical Properties

[ Molecular Formula ]:
C18H21N5O3

[ Molecular Weight ]:
355.39